(firstQuint)Safety and Efficacy Study of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients.

 The objective of this study was to assess the safety and efficacy of eculizumab in Japanese patients with hemolytic PNH.

 In addition, the pharmacokinetics (PK) and pharmacodynamics (PD) of eculizumab in Japanese patients were assessed and compared to that of non-Japanese patients who had participated earlier studies of eculizumab treatment in hemolytic PNH.

.

 Safety and Efficacy Study of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients@highlight

A study to assess the safety and efficacy of eculizumab in Japanese patients with hemolytic PNH.

